
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Elusys Therapeutics is dedicated to delivering innovative medical countermeasures that enable fast, effective, and durable protection against infectious agents. Our goal is to accelerate the development and commercialization of novel biodefense solutions, such as our anthrax antitoxin ANTHIM (obiltoxaximab), for strategic government partners
Biodefense,anthrax,anthim,nyxthracis,and obiltoxaximab
Elusys therapeutics, inc operates in the Biotechnology research industry.
Elusys therapeutics, inc's revenue is 11m - 100m
Elusys therapeutics, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.